Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
BioCryst Pharmaceuticals, Inc.
(NQ:
BCRX
)
1.790
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
4:00 PM EDT, Jun 18, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about BioCryst Pharmaceuticals, Inc.
< Previous
1
2
3
4
5
6
7
8
Next >
BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008
July 31, 2008
from
PR Newswire
BeaconEquity.com Issues Technical Trade Alerts on Market Movers: XOHO, SCUR, BCRX, CPST, TUNE, EMIS
July 29, 2008
from
PR Newswire
BioCryst Reports Positive Preliminary Results of a Shionogi & Co., Ltd. Sponsored Phase II Study of I.V. Peramivir for the Treatment of Influenza in the Outpatient Setting
July 28, 2008
from
PR Newswire
BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
July 10, 2008
from
PR Newswire
William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals
June 18, 2008
from
PR Newswire
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes
June 17, 2008
from
PR Newswire
New Analyst Reports for REAL GOODS SOLAR INC, HOLOGIC INC, ARENA PHARMACEUTICALS INC, and BIOCRYST PHARMACEUTICALS INC
May 08, 2008
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Blue Sea Investment
Read More
from
Marketwired News Releases
BioCryst Reports First Quarter 2008 Financial Results and Clinical Update
May 08, 2008
from
PR Newswire
BioCryst Pharmaceuticals to Announce First Quarter 2008 Financial Results on May 8, 2008
May 01, 2008
from
PR Newswire
BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update
March 04, 2008
from
PR Newswire
BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008
February 28, 2008
from
PR Newswire
BioCryst Updates Peramivir Clinical Development Plan
January 23, 2008
from
PR Newswire
BioCryst Strengthens Its Expertise in Clinical Development By Adding Thomas J. Simon, M.D. as Interim Chief Medical Officer To Meet Growing Product Development and Commercial Opportunities
January 10, 2008
from
PR Newswire
Data Presented at 2007 ASH Meeting Demonstrate Activity of Forodesine HCl as a Single Agent or in Combination With Bendamustine in Certain Types of Leukemia and Lymphoma
December 14, 2007
from
PR Newswire
BioCryst Announces Presentation of Data Detailing Synergistic Activity of Forodesine HCl With Bendamustine in Chronic Lymphocytic Leukemia (CLL)
December 10, 2007
Data to be Presented at the 2007 American Society of Hematology (ASH) Annual Meeting
Read More
from
PR Newswire
BioCryst Provides Forodesine HCl Update
December 06, 2007
from
PR Newswire
BioCryst Reports Third Quarter 2007 Financial Results and Corporate Update
November 08, 2007
Lead Programs Continue Late-Stage Clinical Progress
Read More
from
PR Newswire
BioCryst to Release Third Quarter 2007 Financial Results on Thursday, November 8, 2007
November 06, 2007
CONFERENCE CALL AND WEBCAST TO FOLLOW
Read More
from
PR Newswire
BioCryst Initiates Enrollment in Pivotal Trial of Forodesine HCL in Patients with Cutaneous T-Cell Lymphoma (CTCL)
October 12, 2007
from
PR Newswire
BioCryst to Present at UBS 2007 Global Life Sciences Conference
September 24, 2007
from
PR Newswire
BioCryst Reports Preliminary Results From a Phase II Clinical Trial of Peramivir in Subjects With Acute Influenza
September 19, 2007
from
PR Newswire
BioCryst to Present at the BioCentury NewsMakers in the Biotech Industry Conference
August 31, 2007
from
PR Newswire
BioCryst Completes $65.3 Million Private Placement Financing
August 09, 2007
from
PR Newswire
BioCryst Reports Second Quarter 2007 Financial Results
August 09, 2007
from
PR Newswire
BioCryst Appoints Elliott T. Berger, Ph.D., Senior Vice President of Regulatory Affairs
August 08, 2007
from
PR Newswire
BioCryst Announces $65.3 Million Private Placement Financing
August 06, 2007
from
PR Newswire
BioCryst to Release Second Quarter 2007 Financial Results on Thursday, August 9, 2007
August 02, 2007
Conference Call and Webcast to Follow
Read More
from
PR Newswire
BioCryst Announces Realignment and Strengthening of the Company's Executive Management Team
July 26, 2007
Stuart Grant Appointed Senior Vice President and Chief Financial Officer
Read More
from
PR Newswire
BioCryst Initiates Phase II Clinical Trial to Evaluate Intravenous Peramivir in Patients Hospitalized With Influenza
July 24, 2007
from
PR Newswire
Roche and BioCryst Advance BCX-4208/R3421 Into Phase II Psoriasis Trial
July 16, 2007
from
PR Newswire
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here